{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:19:55Z","timestamp":1787822395144,"version":"build-2784847793"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: While total neoadjuvant therapy (TNT) is increasingly adopted, conventionally fractionated neoadjuvant chemoradiotherapy (CRT) followed by surgery remains the standard approach for many patients with locally advanced rectal cancer (LARC). Tumor regression following neoadjuvant therapy varies, potentially influencing oncologic outcomes. This study aimed to evaluate the association between pathological complete response (pCR) and long-term overall survival (OS) and disease-free survival (DFS) in patients with LARC undergoing neoadjuvant therapy and surgery. Materials and Methods: This retrospective study included patients who received long-course radiotherapy with concurrent capecitabine, followed by curative-intent surgery between January 2006 and January 2017. Patients were stratified according to the presence or absence of pCR. The primary outcomes were 5-year OS and DFS; secondary outcomes included locoregional recurrence and distant metastasis rates. Results: Among 327 patients, 47 (14.4%) achieved pCR. Patients with pCR had significantly lower pretreatment clinical T stage (p = 0.033) and clinical N stage (p = 0.049) and were more frequently classified as clinical stage II (55.3% vs. 40.0%, p = 0.049). Long-term oncological analyses included 322 patients after the exclusion of five early postoperative deaths. Locoregional recurrence (6.4% vs. 9.8%, p = 0.59) and distant metastasis (10.6% vs. 20.0%, p = 0.15) were numerically less frequent in the pCR group but did not differ significantly. Five-year OS was 91.5% in the pCR group and 73.1% in the non-pCR group (log-rank p = 0.027), while 5-year DFS was 85.1% and 61.5%, respectively (log-rank p = 0.008). After adjustment for age, sex, tumor location, pretreatment clinical T and N stage, and the CRT-to-surgery interval, pCR remained associated with improved DFS (adjusted HR 0.542, 95% CI 0.296\u20130.994, p = 0.048). In contrast, the association between pCR and OS was attenuated and did not reach statistical significance (adjusted HR 0.575, 95% CI 0.305\u20131.083, p = 0.087). Conclusion: pCR following neoadjuvant therapy in patients with LARC is associated with favorable long-term oncological outcomes. After adjustment for baseline clinical characteristics, pCR remained associated with improved DFS, whereas its association with OS was attenuated and did not reach statistical significance. These findings support the prognostic relevance of pCR while emphasizing the contribution of baseline disease characteristics to long-term survival.<\/jats:p>","DOI":"10.3390\/medicina62091639","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:02:27Z","timestamp":1787817747000},"page":"1639","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Pathological Complete Response with Long-Term Oncological Outcomes After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Retrospective Analysis of 327 Patients"],"prefix":"10.3390","volume":"62","author":[{"given":"Berk","family":"Sertoz","sequence":"first","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Erozkan","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep","family":"Temel","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sezak","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak","family":"Doganavsargil","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Bozbiyik","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemil","family":"Caliskan","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Akgun","sequence":"additional","affiliation":[{"name":"Colorectal Surgery Division, Department of General Surgery, Ege University Hospital, 35100 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial","volume":"373","author":"Stephens","year":"2009","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1245\/s10434-009-0335-6","article-title":"Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: A single-institution experience after a median follow-up of 95 months","volume":"16","author":"Pucciarelli","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejso.2009.11.011","article-title":"Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial","volume":"36","author":"Kusters","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2004.06.206","article-title":"Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy","volume":"61","author":"Chan","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","article-title":"Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence","volume":"18","author":"Stocchi","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","article-title":"Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: Preliminary results of a multicenter, nonrandomized phase II prospective trial","volume":"254","author":"Smith","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_8","first-page":"2831","article-title":"Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response","volume":"17","author":"Smith","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/cncr.22625","article-title":"Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer","volume":"109","author":"Das","year":"2007","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","article-title":"Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal cancer revisited: Updated results of the CAO\/ARO\/AIO-94 trial","volume":"32","author":"Fokas","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Assaf, D., Lawrence, Y., Margalit, O., Shacham-Shmueli, E., Bear, L., Elbaz, N., Lebedayev, A., Ram, E., Anderson, Y., and Gruper, O. (2025). Predictors and Long-Term Outcomes of Pathological Complete Response Following Neoadjuvant Treatment and Radical Surgery for Locally Advanced Rectal Cancer. J. Clin. Med., 14.","DOI":"10.3390\/jcm14124251"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomized, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","article-title":"Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients","volume":"72","author":"Capirci","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/codi.14106","article-title":"Prognostic value of tumour regression grade in locally advanced rectal cancer: A systematic review and meta-analysis","volume":"20","author":"Kong","year":"2018","journal-title":"Colorectal Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","article-title":"Complete pathologic response after combined modality treatment for rectal cancer and long-term survival","volume":"19","author":"Zorcolo","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"106962","DOI":"10.1016\/j.ejso.2023.06.014","article-title":"Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response","volume":"49","author":"Vigorita","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: Long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5\u00d75 Gy and consolidation chemotherapy: Polish II trial","volume":"30","author":"Pietrzak","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_23","first-page":"326","article-title":"Oncological outcomes and response rate after total neoadjuvant therapy for locally advanced rectal cancer: A network meta-analysis comparing induction vs consolidation chemotherapy vs standard chemoradiation","volume":"23","author":"Bedrikovetski","year":"2024","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1200\/OP-25-00530","article-title":"Critical evaluation of total neoadjuvant therapy for locally advanced rectal cancer","volume":"22","author":"Ubink","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_25","unstructured":"Sertoz, B., Erozkan, K., and Bozbiyik, O. (2025, January 16\u201320). Lokal ileri evre rektal kanserde neoadjuvan tedavi sonras\u0131 patolojik tam yan\u0131t\u0131n uzun vadeli sa\u011fkal\u0131m \u00fczerindeki prognostik etkisi. Proceedings of the 20th National Turkish Society of Colon and Rectal Surgery (TSCRS) Congress, Antalya, Turkey."},{"key":"ref_26","unstructured":"Sertoz, B., Erozkan, K., and Bozbiyik, O. (2025, January 10\u201312). Prognostic impact of pathologic complete response on long-term survival in locally advanced rectal cancer following neoadjuvant treatment. Proceedings of the European Society of Coloproctology (ESCP) Tripartite Colorectal Meeting, Paris, France."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1639\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:39:01Z","timestamp":1787819941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091639"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091639","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}